In The News

Apr 26, 20231 min read

Dr. Katrin Rupalla Interviewed by Global Business Reports

Life Sciences issue 2023 highlights companies making a difference with their research Read the full interview with Dr. Rupalla in which...

Jan 31, 20231 min read

Ymmunobio get ownership rights to NPTXR antibodies. Read more here: https://www.drugdiscoverytrends.com/ymmunobio-gets-ownership-rights-t...

Jan 13, 20231 min read

Michel Janicot will serve in the newly created position of chief development officer. https://www.fiercebiotech.com/biotech/chutes-ladder...

Jun 13, 20221 min read

Ymmunobio Signs Collaboration Agreement with YUMAB https://www.biopharmadive.com/press-release/20220614-ymmunobio-signs-collaboration-agr...

Apr 10, 20221 min read

Ymmunobio AG Signs Patent Purchase Agreement with LeukoGmbH https://www.pharmtech.com/view/ymmunobio-ag-signs-patent-purchase-agreement-w...